Summary:
- The article discusses a study that found the popular weight loss drug Ozempic (semaglutide) can lead to heart shrinkage in some users.
- The study, conducted by researchers at the University of California, San Diego, analyzed data from over 700 patients and found that those taking Ozempic experienced a significant reduction in the size of their left ventricle, the main pumping chamber of the heart.
- The researchers suggest that this heart shrinkage could potentially lead to long-term cardiovascular problems and emphasize the need for close monitoring of patients taking Ozempic and other similar medications.